Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
Clinical trial NCT00754013 · TERMINATED
Trial details
- NCT number
- NCT00754013
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.